Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Analyses of the cag pathogenicity island of Helicobacter pylori.

Akopyants NS, Clifton SW, Kersulyte D, Crabtree JE, Youree BE, Reece CA, Bukanov NO, Drazek ES, Roe BA, Berg DE.

Mol Microbiol. 1998 Apr;28(1):37-53.

2.

Decrease in gastric permeability to sucrose following cure of Helicobacter pylori infection.

Goodgame RW, Malaty HM, el-Zimaity HM, Graham DY.

Helicobacter. 1997 Mar;2(1):44-7.

PMID:
9432322
3.

Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa.

Haeberle HA, Kubin M, Bamford KB, Garofalo R, Graham DY, El-Zaatari F, Karttunen R, Crowe SE, Reyes VE, Ernst PB.

Infect Immun. 1997 Oct;65(10):4229-35.

4.

Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer.

D'Elios MM, Manghetti M, Almerigogna F, Amedei A, Costa F, Burroni D, Baldari CT, Romagnani S, Telford JL, Del Prete G.

Eur J Immunol. 1997 Jul;27(7):1751-5.

PMID:
9247587
6.

Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan.

Ito Y, Azuma T, Ito S, Miyaji H, Hirai M, Yamazaki Y, Sato F, Kato T, Kohli Y, Kuriyama M.

J Clin Microbiol. 1997 Jul;35(7):1710-4.

7.

Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori-associated antral gastritis.

Hatz RA, Rieder G, Stolte M, Bayerdörffer E, Meimarakis G, Schildberg FW, Enders G.

Gastroenterology. 1997 Jun;112(6):1908-19.

PMID:
9178683
8.

Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.

Parsonnet J, Friedman GD, Orentreich N, Vogelman H.

Gut. 1997 Mar;40(3):297-301.

9.
10.

Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis.

Berstad AE, Brandtzaeg P, Stave R, Halstensen TS.

Gut. 1997 Feb;40(2):196-203.

11.

Expression of cytokine mRNA in gastric mucosa with Helicobacter pylori infection.

Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J.

Scand J Gastroenterol. 1995 Dec;30(12):1153-9.

PMID:
9053967
12.

Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori.

Atherton JC, Peek RM Jr, Tham KT, Cover TL, Blaser MJ.

Gastroenterology. 1997 Jan;112(1):92-9.

PMID:
8978347
13.

Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa.

Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J.

Gastroenterology. 1996 Jun;110(6):1744-52.

PMID:
8964399
14.

cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors.

Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A.

Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14648-53.

15.
16.

Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection.

Beales IL, Crabtree JE, Scunes D, Covacci A, Calam J.

Eur J Gastroenterol Hepatol. 1996 Jul;8(7):645-9.

PMID:
8853252
17.

Characterization of lymphocytic infiltrates in Helicobacter pylori-associated gastritis.

Hatz RA, Meimarakis G, Bayerdorffer E, Stolte M, Kirchner T, Enders G.

Scand J Gastroenterol. 1996 Mar;31(3):222-8.

PMID:
8833350
19.

Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis.

Negrini R, Savio A, Poiesi C, Appelmelk BJ, Buffoli F, Paterlini A, Cesari P, Graffeo M, Vaira D, Franzin G.

Gastroenterology. 1996 Sep;111(3):655-65.

PMID:
8780570
20.

The role of lipopolysaccharide in Helicobacter pylori pathogenesis.

Moran AP.

Aliment Pharmacol Ther. 1996 Apr;10 Suppl 1:39-50. Review.

PMID:
8730258

Supplemental Content

Support Center